- Home
- Publications
- Publication Search
- Publication Details
Title
TCR engineered T cells for solid tumor immunotherapy
Authors
Keywords
-
Journal
Experimental Hematology & Oncology
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-20
DOI
10.1186/s40164-022-00291-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial
- (2022) Cunte Chen et al. JCI Insight
- The role of NFAT in the pathogenesis and targeted therapy of hematological malignancies
- (2022) Rili Gao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- T-Cell Immunotherapy against Mutant KRAS for Pancreatic Cancer
- (2022) Cornelis J.M. Melief NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
- (2022) Rom Leidner et al. NEW ENGLAND JOURNAL OF MEDICINE
- TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
- (2021) Nisha B. Nagarsheth et al. NATURE MEDICINE
- Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
- (2021) Qijie Zhao et al. Frontiers in Immunology
- TCR gene-engineered cell therapy for solid tumors
- (2021) Elaine Tan et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
- (2021) Apostolia-Maria Tsimberidou et al. Journal of Hematology & Oncology
- Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
- (2021) Christopher T. Su et al. Journal of Hematology & Oncology
- Single‐Cell RNA‐Seq of T Cells in B‐ALL Patients Reveals an Exhausted Subset with Remarkable Heterogeneity
- (2021) Xiaofang Wang et al. Advanced Science
- Novel strategies for immuno-oncology breakthroughs with cell therapy
- (2021) Hongtao Liu et al. Biomarker Research
- Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
- (2021) Fanping Meng et al. Hepatology International
- Targeting CD47 for cancer immunotherapy
- (2021) Zhongxing Jiang et al. Journal of Hematology & Oncology
- CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity
- (2021) Jiangzhou Shi et al. Journal of Hematology & Oncology
- The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment
- (2020) Andreas Bikfalvi et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- The Emerging Landscape of Immune Cell Therapies
- (2020) Evan W. Weber et al. CELL
- Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
- (2020) Hanren Dai et al. Journal of Hematology & Oncology
- Gene modification strategies for next-generation CAR T cells against solid cancers
- (2020) Yonggui Tian et al. Journal of Hematology & Oncology
- Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients with Elevated CEA
- (2020) Pat Gulhati et al. JNCI-Journal of the National Cancer Institute
- Recent advances in CAR-T cell engineering
- (2020) Ruihao Huang et al. Journal of Hematology & Oncology
- Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients
- (2020) Si-Yang Liu et al. Biomarker Research
- Data from the third dose cohort of an ongoing study with ADP-A2AFP SPEAR T cells
- (2020) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Engineering better chimeric antigen receptor T cells
- (2020) Hao Zhang et al. Experimental Hematology & Oncology
- T cell receptor-engineered T cells for leukemia immunotherapy
- (2019) Yikai Zhang et al. Cancer Cell International
- NK cells specifically TCR-dressed to kill cancer cells
- (2019) Nadia Mensali et al. EBioMedicine
- The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review
- (2019) Jianxiang Zhang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Deciphering CD4+ T cell specificity using novel MHC–TCR chimeric receptors
- (2019) Jan Kisielow et al. NATURE IMMUNOLOGY
- Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies
- (2019) Lorraine Springuel et al. BIODRUGS
- T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
- (2019) Smita S. Chandran et al. IMMUNOLOGICAL REVIEWS
- T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
- (2019) Stacey L. Doran et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma
- (2019) Yuexin Xu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Engineered T Cell Therapy for Cancer in the Clinic
- (2019) Lijun Zhao et al. Frontiers in Immunology
- Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
- (2019) Joseph P Sanderson et al. OncoImmunology
- The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
- (2019) Peter G. Hendrickson et al. OncoImmunology
- Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
- (2019) Indu Ramachandran et al. Journal for ImmunoTherapy of Cancer
- Cancer immunotherapy with lymphocytes genetically engineered with T cell receptors for solid cancers
- (2019) Lei Chen et al. IMMUNOLOGY LETTERS
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
- (2018) Remy Thomas et al. Frontiers in Immunology
- PRAME Expression in Melanocytic Tumors
- (2018) Cecilia Lezcano et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1
- (2017) Kunio Iura et al. HUMAN PATHOLOGY
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
- (2017) Waseem Qasim et al. Science Translational Medicine
- Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell–Treated Mice
- (2016) Marie-Louise Sentman et al. JOURNAL OF IMMUNOLOGY
- Ionic immune suppression within the tumour microenvironment limits T cell effector function
- (2016) Robert Eil et al. NATURE
- Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes
- (2016) Alla N. Shatrova et al. PLoS One
- Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
- (2016) D. T. Teachey et al. Cancer Discovery
- Generation of V α13/β21+T cell specific target CML cells by TCR gene transfer
- (2016) Xianfeng Zha et al. Oncotarget
- Toxicity and management in CAR T-cell therapy
- (2016) Challice L Bonifant et al. Molecular Therapy-Oncolytics
- Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
- (2015) S. Kageyama et al. CLINICAL CANCER RESEARCH
- Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient
- (2015) Waseem Qasim et al. JOURNAL OF HEPATOLOGY
- The Tumor Antigen NY-ESO-1 Mediates Direct Recognition of Melanoma Cells by CD4+T Cells after Intercellular Antigen Transfer
- (2015) Jean Francois Fonteneau et al. JOURNAL OF IMMUNOLOGY
- Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor
- (2015) Joost H van den Berg et al. MOLECULAR THERAPY
- Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
- (2014) T. Chodon et al. CLINICAL CANCER RESEARCH
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer
- (2014) B Berdien et al. GENE THERAPY
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T Cell Receptor Transfer to T Cells Generates Functional Effector Cells without Mixed TCR Dimers In Vivo
- (2014) L. T. van der Veken et al. JOURNAL OF IMMUNOLOGY
- RNAi-mediated TCR Knockdown Prevents Autoimmunity in Mice Caused by Mixed TCR Dimers Following TCR Gene Transfer
- (2014) Mario Bunse et al. MOLECULAR THERAPY
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes
- (2013) D. Abate-Daga et al. BLOOD
- The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
- (2013) Chen Lin et al. Cancer Cell International
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
- (2013) Thomas Gaj et al. TRENDS IN BIOTECHNOLOGY
- New insights into antigen specific immunotherapy for chronic myeloid leukemia
- (2012) Yangqiu Li et al. Cancer Cell International
- Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
- (2012) Elena Provasi et al. NATURE MEDICINE
- Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety
- (2011) T. Ochi et al. BLOOD
- Genetic Engineering of Murine CD8+ and CD4+ T Cells for Preclinical Adoptive Immunotherapy Studies
- (2011) Sid P. Kerkar et al. JOURNAL OF IMMUNOTHERAPY
- MAGE A3 antigen-specific cancer immunotherapeutic
- (2010) Nir Peled et al. Immunotherapy
- Both CD4 and CD8 T Cells Mediate Equally Effective In Vivo Tumor Treatment When Engineered with a Highly Avid TCR Targeting Tyrosinase
- (2010) T. L. Frankel et al. JOURNAL OF IMMUNOLOGY
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
- (2010) Gavin M Bendle et al. NATURE MEDICINE
- Mixed T cell receptor dimers harbor potentially harmful neoreactivity
- (2010) M. M. van Loenen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- T-Cell Receptor Gene Therapy of Established Tumors in a Murine Melanoma Model
- (2009) John D. Abad et al. JOURNAL OF IMMUNOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started